CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- 4 Grant or award President and CEO acquired 1,979,346 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $7.38 ($36,900)
- 4 Open-market buy Director bought 5,000 shares at $7.37 ($36,850)
- 4 Open-market buy Chief Financial Officer bought 4,545 shares at $7.90 ($35,906)
- 4 Open-market buy Chairman and CEO bought 10,000 shares at $7.59 ($75,900)
- 4 Open-market buy Director bought 10,000 shares at $7.62 ($76,231)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy SVP & Chief Accounting Officer bought 1,503 shares at $3.88 ($5,832)
- 4 Open-market buy Chief Financial Officer bought 4,979 shares at $3.88 ($19,319)
- 4 Open-market buy Executive VP and COO bought 5,000 shares at $3.88 ($19,400)
- 4 Gift President gave 3,000 shares (gift)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 15 · 291 filings